DBIA
EW icon

Dumont & Blake Investment Advisors’s Edwards Lifesciences EW Stock Holding History

Dumont & Blake Investment Advisors’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-8,400
Closed -$178K – 168
2014
Q4 		$178K Buy
+8,400
New +$169K 0.09% 142

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Dumont & Blake Investment Advisors's EW Position: Q1 2015 in Review

Dumont & Blake Investment Advisors sold out of Edwards Lifesciences (EW) in Q1 2015, closing a stake of 8,400 shares — an estimated $178K sold.

Dumont & Blake Investment Advisors first reported a position in EW in Q4 2014 and held it in 1 quarter. The position peaked at $178K in Q4 2014. 575 funds tracked by Wall St. Rank hold EW as of Q1 2015.

  • Dumont & Blake Investment Advisors reported no remaining Edwards Lifesciences position as of Q1 2015 after selling out during the quarter.
  • Dumont & Blake Investment Advisors sold 8,400 Edwards Lifesciences shares in Q1 2015, an estimated $178K.
  • Dumont & Blake Investment Advisors first reported a position in Edwards Lifesciences in Q4 2014 and held it in 1 quarter.
  • Dumont & Blake Investment Advisors's Edwards Lifesciences position peaked at $178K in Q4 2014.
  • 575 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2015.

Based on Dumont & Blake Investment Advisors's 13F filing for Q1 2015, filed 28 Apr 2015.